Get the top three things to know in women's health + wellness, every weekday:

FDA Nominee Says He’ll ‘Look at the Data’ on Abortion Pill, Despite 25 Years of Use

What: The nominee to lead the FDA, Dr. Marty Makary, had his nomination hearing in the Senate today. He said he has “no preconceived plans” to ban the abortion pill and would “take a hard look at the data.” (The comments were similar to what HHS Sec. Kennedy said at his hearing last month.) Banning the abortion pill is a major focus for anti-abortion groups that support President Trump.

Key line: “Mifepristone was approved roughly 25 years ago and FDA scientists have repeatedly reaffirmed its safety over the years, easing limits on its use, including eliminating a requirement that patients pick it up in person.”

Source: AP

More News Snippets
Women’s Pain: Maybe It’s Leptin

University of Calgary researchers found that female mice release leptin, a hormone associated with heightened pain sensitivity, which may explain why women experience more pain.